LifeTein Becomes a University of Maryland’s Preferred Vendor

South Plainfield, NJ, August 22, 2012 --(PR.com)-- LifeTein, LLC., a leading provider of custom peptide and antibody services, announced a partnership with the University of Maryland. As one of the School of Medicine’s preferred vendors in the biomedical research supply core (Bioresco), LifeTein will provide custom peptide synthesis services for scientists and researchers of the University of Maryland at Baltimore.

LifeTein's PeptideSyn technology is a platform for the synthesis of peptides for use in research and pharmaceutical applications. PeptideSyn has been used for testing of multiple selected biologically active peptides including long and short peptides and peptides containing D-amino acids or fluorescent labeled peptides.

"Our platform is optimized to provide a continuous flow of synthesized peptides, reducing costs while maintaining quality," says Faith Lee, LifeTein’s Director of Quality Assurance. “It has been proven to enhance the efficiency of synthesis. Researchers from University of Maryland will benefit from the quality products provided by LifeTein’s unique, low-cost services.”

“The Biopolymer/Genomics Core Facility is closing down its Peptide synthesis services due to increased costs associated with the service, and as a result of outdated instrumentation. We have taken this opportunity to identify commercial sources to take over this service for us, through a competitive bidding process, to assure that UMB investigators will receive these services at a substantially lower rate,” reads the University of Maryland, Bioresco website.